ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 291

Factors Explaining Patient Perspective in Psoriasis and Psoriatic Arthritis: The Role of Inflammation and Structural Damage Detected by Ultrasound

Tania Gudu1, Ilaria Padovano 1, Hélène Gouze 2, François Vidal 1, Emmanuel Mahé 3, Leire Lara Gonzalez 4, Alexis Guyot 4, Philippe Saiag 4, Isabelle Bourgault Villada 4, Sophie Ruel-Gagné 1, Gilles Hayem 1, Félicie Costantino 5, Maxime Breban 6 and Maria-Antonietta D’Agostino 7, 1Rheumatology Department, APHP, Ambroise Paré Hospital, Boulogne Billancourt, France, 2Rheumatology Department, APHP, Ambroise Paré Hospital, Bolougne Billancourt, France, 3Dermatology Department, Victor Dupouy Hospital, Argenteuil, France, 4Dermatology Department, Ambroise Paré Hospital, Boulogne Billancourt, France, 5UMR1173, INSERM/Versailles-Saint Quentin University, France Ambroise Paré Hospital (AP-HP) Department of Rheumatology, Boulogne-Billancourt, France, Boulogne Billancourt, France, 6UMR1173, INSERM/Versailles-Saint Quentin University, France Ambroise Paré Hospital (AP-HP) Department of Rheumatology, Boulogne-Billancourt, France, Boulogne Billancourt, 7Department of Rheumatology, APHP, Hôpital Ambroise Paré, Paris, France

Meeting: ACR/ARP Annual Meeting 2019

Keywords: patient outcomes and ultrasound, psoriasis, Psoriatic arthritis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Imaging Of Rheumatic Diseases Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Patient reported outcomes (PROs) reflect patients’ opinion on disease activity, impact of disease, quality of life (QoL), disability and are essential in the assessment of PsA patients. PROs may be influenced by several factors other than disease activity and severity. US is an objective tool to evaluate inflammation and structural damage in PsA. This cross-sectional study aimed at evaluating the role of US-detected inflammation (synovitis, tenosynovitis, enthesitis, dactylitis) and structural damage (erosions, enthesophytes, osteophytes and cortical irregularities), according to the OMERACT definitions and scoring [1], to explain PROs in PsA and to compare that to psoriasis (PsO) patients with and without musculoskeletal (MSK) symptoms.

Methods: PsA (CASPAR criteria) [2], PsO with MSK symptoms without fulfilling CASPAR criteria (symptoPsO) and PsO with no MSK symptoms (asymptoPsO) were included. Socio-demographic characteristics, comorbidities, disease duration and treatment were collected. All patients underwent dermatological and rheumatologic assessment: PsO severity, swollen joint count (SJC), tender JC (TJC), number of dactylitis and enthesitis, fibromyalgia criteria; and US evaluation on joints, tendons and entheses as shown in figure 1. PROs were evaluated in all patients: assessment of skin psoriasis and of fatigue on a numeric rating scale (NRS), HAQ and QoL assessed by SF36. Variables were compared across groups (chi square or one-way ANOVA test). Correlations were evaluated using Spearman’s test.

Results: One hundred fifty eight patients (54 PsA, 52 symptoPsO and 52 asymptoPsO) with similar socio-demographic characteristics and PsO duration were included (table 1). Most of PsA patients had low/moderate disease activity. With the exception of US enthesophytes, all US changes were significantly higher in PsA, followed by symptoPsO patients.

Across all 3 groups, all PROs correlated mainly with demographic variables, comorbidities, TJC, number of enthesitis, skin severity, depression and fibromyalgia (r=0.29-0.66). SymptoPsO and PsA reported similar scores of fatigue and impact on some QoL domains (vitality, pain, general health, social and mental), significantly higher than asymptoPsO. Only in PsA, HAQ correlated with the total number of US enthesitis (r=0.35, p=0.01) and of joints with ostheophytes/cortical irregularities (r=0.28, p=0.04) as well as the physical function domain of SF36 with the number of joints with ostheophytes/cortical irregularities (r=-0.33, p=0.02).

Conclusion: Quality of life, disability and fatigue were more impaired in PsA and symptoPsO patients than asymptoPsO. In all groups, PROs were mostly associated with socio-demographic characteristics, comorbidities and some clinical variables rather than objective measures such as US changes.

Acknowledgement: The study was supported by a grant from The PARTNER Psoriatic Arthritis Network fellowship.

References:

  1. Bruyn GA et al. J Rheumatol 2019 

  1. Taylor W et al. Arthritis Rheum 2006

Figure 1. Anatomical sites of US evaluation: joints, entheses and tendons


table 1

Table 1. Characteristics of the patients included in the 3 groups: PsA patients, patients with psoriasis with MSK symptoms -symptoPsO- and patients with psoriasis and no MSK symptoms -asymptoPsO-

PsA: psoriatic arthritis; PsO: psoriasis; PASI: Psoriasis Area and Severity Index; TJC: total tender joint count; SJC: total swollen joint count; N: number; SD: standard deviation; NRS: numeric rating scale; SF36: Medical Outcome Study Short Form-36; PF: Physical Functioning; RP: Physical Role functioning; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social role Functioning; MH: Mental Health; RE: Emotional Role functioning
* Number of enthesitis was calculated according to the Spondyloarthritis Research Consortium of Canada -SPARCC- Enthesitis Index


Disclosure: T. Gudu, None; I. Padovano, None; H. Gouze, None; F. Vidal, None; E. Mahé, None; L. Lara Gonzalez, None; A. Guyot, None; P. Saiag, None; I. Bourgault Villada, None; S. Ruel-Gagné, None; G. Hayem, None; F. Costantino, None; M. Breban, None; M. D’Agostino, None.

To cite this abstract in AMA style:

Gudu T, Padovano I, Gouze H, Vidal F, Mahé E, Lara Gonzalez L, Guyot A, Saiag P, Bourgault Villada I, Ruel-Gagné S, Hayem G, Costantino F, Breban M, D’Agostino M. Factors Explaining Patient Perspective in Psoriasis and Psoriatic Arthritis: The Role of Inflammation and Structural Damage Detected by Ultrasound [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/factors-explaining-patient-perspective-in-psoriasis-and-psoriatic-arthritis-the-role-of-inflammation-and-structural-damage-detected-by-ultrasound/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARP Annual Meeting 2019

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-explaining-patient-perspective-in-psoriasis-and-psoriatic-arthritis-the-role-of-inflammation-and-structural-damage-detected-by-ultrasound/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology